291 related articles for article (PubMed ID: 19808966)
1. Aldehyde dehydrogenase-expressing colon stem cells contribute to tumorigenesis in the transition from colitis to cancer.
Carpentino JE; Hynes MJ; Appelman HD; Zheng T; Steindler DA; Scott EW; Huang EH
Cancer Res; 2009 Oct; 69(20):8208-15. PubMed ID: 19808966
[TBL] [Abstract][Full Text] [Related]
2. Transition from colitis to cancer: high Wnt activity sustains the tumor-initiating potential of colon cancer stem cell precursors.
Shenoy AK; Fisher RC; Butterworth EA; Pi L; Chang LJ; Appelman HD; Chang M; Scott EW; Huang EH
Cancer Res; 2012 Oct; 72(19):5091-100. PubMed ID: 22902411
[TBL] [Abstract][Full Text] [Related]
3. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.
Huang EH; Hynes MJ; Zhang T; Ginestier C; Dontu G; Appelman H; Fields JZ; Wicha MS; Boman BM
Cancer Res; 2009 Apr; 69(8):3382-9. PubMed ID: 19336570
[TBL] [Abstract][Full Text] [Related]
4. ALDH as a marker for enriching tumorigenic human colonic stem cells.
Shenoy A; Butterworth E; Huang EH
Methods Mol Biol; 2012; 916():373-85. PubMed ID: 22914954
[TBL] [Abstract][Full Text] [Related]
5. Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan.
Emmink BL; Van Houdt WJ; Vries RG; Hoogwater FJ; Govaert KM; Verheem A; Nijkamp MW; Steller EJ; Jimenez CR; Clevers H; Borel Rinkes IH; Kranenburg O
Gastroenterology; 2011 Jul; 141(1):269-78. PubMed ID: 21459094
[TBL] [Abstract][Full Text] [Related]
6. Dysplastic lesions in inflammatory bowel disease show increased positivity for the stem cell marker aldehyde dehydrogenase.
Toll AD; Boman BM; Palazzo JP
Hum Pathol; 2012 Feb; 43(2):238-42. PubMed ID: 21820149
[TBL] [Abstract][Full Text] [Related]
7. Aldehyde dehydrogenase-1 is a specific marker for stem cells in human lung adenocarcinoma.
Liang D; Shi Y
Med Oncol; 2012 Jun; 29(2):633-9. PubMed ID: 21484084
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence endoscopic detection of murine colitis-associated colon cancer by topically applied enzymatically rapid-activatable probe.
Mitsunaga M; Kosaka N; Choyke PL; Young MR; Dextras CR; Saud SM; Colburn NH; Sakabe M; Nagano T; Asanuma D; Urano Y; Kobayashi H
Gut; 2013 Aug; 62(8):1179-86. PubMed ID: 22698650
[TBL] [Abstract][Full Text] [Related]
9. Early human prostate adenocarcinomas harbor androgen-independent cancer cells.
Fiñones RR; Yeargin J; Lee M; Kaur AP; Cheng C; Sun P; Wu C; Nguyen C; Wang-Rodriguez J; Meyer AN; Baird SM; Donoghue DJ; Haas M
PLoS One; 2013; 8(9):e74438. PubMed ID: 24086346
[TBL] [Abstract][Full Text] [Related]
10. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
11. BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
Wang L; Park P; La Marca F; Than KD; Lin CY
J Cancer Res Clin Oncol; 2015 Jun; 141(6):1013-24. PubMed ID: 25431339
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia promotes the phenotypic change of aldehyde dehydrogenase activity of breast cancer stem cells.
Shiraishi A; Tachi K; Essid N; Tsuboi I; Nagano M; Kato T; Yamashita T; Bando H; Hara H; Ohneda O
Cancer Sci; 2017 Mar; 108(3):362-372. PubMed ID: 28012234
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
[TBL] [Abstract][Full Text] [Related]
14. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.
Ginestier C; Hur MH; Charafe-Jauffret E; Monville F; Dutcher J; Brown M; Jacquemier J; Viens P; Kleer CG; Liu S; Schott A; Hayes D; Birnbaum D; Wicha MS; Dontu G
Cell Stem Cell; 2007 Nov; 1(5):555-67. PubMed ID: 18371393
[TBL] [Abstract][Full Text] [Related]
15. Fucosylation Deficiency in Mice Leads to Colitis and Adenocarcinoma.
Wang Y; Huang D; Chen KY; Cui M; Wang W; Huang X; Awadellah A; Li Q; Friedman A; Xin WW; Di Martino L; Cominelli F; Miron A; Chan R; Fox JG; Xu Y; Shen X; Kalady MF; Markowitz S; Maillard I; Lowe JB; Xin W; Zhou L
Gastroenterology; 2017 Jan; 152(1):193-205.e10. PubMed ID: 27639802
[TBL] [Abstract][Full Text] [Related]
16. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.
Marcato P; Dean CA; Pan D; Araslanova R; Gillis M; Joshi M; Helyer L; Pan L; Leidal A; Gujar S; Giacomantonio CA; Lee PW
Stem Cells; 2011 Jan; 29(1):32-45. PubMed ID: 21280157
[TBL] [Abstract][Full Text] [Related]
17. Aldehyde dehydrogenase activity among primary leukemia cells is associated with stem cell features and correlates with adverse clinical outcomes.
Ran D; Schubert M; Pietsch L; Taubert I; Wuchter P; Eckstein V; Bruckner T; Zoeller M; Ho AD
Exp Hematol; 2009 Dec; 37(12):1423-34. PubMed ID: 19819294
[TBL] [Abstract][Full Text] [Related]
18. Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy.
Nishikawa S; Konno M; Hamabe A; Hasegawa S; Kano Y; Ohta K; Fukusumi T; Sakai D; Kudo T; Haraguchi N; Satoh T; Takiguchi S; Mori M; Doki Y; Ishii H
Int J Oncol; 2013 Apr; 42(4):1437-42. PubMed ID: 23440340
[TBL] [Abstract][Full Text] [Related]
19. MET signaling in colon cancer stem-like cells blunts the therapeutic response to EGFR inhibitors.
Luraghi P; Reato G; Cipriano E; Sassi F; Orzan F; Bigatto V; De Bacco F; Menietti E; Han M; Rideout WM; Perera T; Bertotti A; Trusolino L; Comoglio PM; Boccaccio C
Cancer Res; 2014 Mar; 74(6):1857-69. PubMed ID: 24448239
[TBL] [Abstract][Full Text] [Related]
20. Aldehyde dehydrogenase activity in cancer stem cells from canine mammary carcinoma cell lines.
Michishita M; Akiyoshi R; Suemizu H; Nakagawa T; Sasaki N; Takemitsu H; Arai T; Takahashi K
Vet J; 2012 Aug; 193(2):508-13. PubMed ID: 22326935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
